13FPulse
中
CT

CTMX CYTOMX THERAPEUTICS INC

2026Q2 · CUSIP 23284F105 · Sector: Healthcare & Biotech

Cooling

Net holder growth weakened from last quarter

Funds that own it
178
Institutions that reported holding it to the SEC
Net increase in holders
0
Last quarter 178 → now 178
How unusual is that
Below average
Stronger than only 36% of US stocks
What the filings say, in one paragraph

178 funds held CTMX at the end of 2026Q2. Buying has come off its highs, but funds are not exiting. On the business itself, revenue over the last 12 months was $18M(YoY -87.0%), return on equity is -26.4%. CTMX has had 6 buying rushes in its history. It sits in the Healthcare & Biotech sector.

How many funds owned it, quarter by quarter

Bars = net change in institutional holders, positive (green) or negative (red). Line = total institutional holders.

2016Q1: holders=48 2016Q2: holders=58 2016Q3: holders=62 2016Q4: holders=68 2017Q1: holders=87 2017Q2: holders=90 2017Q3: holders=97 2017Q4: holders=118 2018Q1: holders=141 2018Q2: holders=140 2018Q3: holders=122 2018Q4: holders=112 2019Q1: holders=113 2019Q2: holders=109 2019Q3: holders=113 2019Q4: holders=120 2020Q1: holders=117 2020Q2: holders=133 2020Q3: holders=128 2020Q4: holders=125 2021Q1: holders=126 2021Q2: holders=121 2021Q3: holders=113 2021Q4: holders=112 2022Q1: holders=117 2022Q2: holders=97 2022Q3: holders=83 2022Q4: holders=81 2023Q1: holders=75 2023Q2: holders=66 2023Q3: holders=61 2023Q4: holders=67 2024Q1: holders=87 2024Q2: holders=73 2024Q3: holders=67 2024Q4: holders=69 2025Q1: holders=66 2025Q2: holders=82 2025Q3: holders=103 2025Q4: holders=122 2026Q1: holders=178 2026Q2: holders=178 -56 -28 +0 +28 +56 43115187 16Q117Q218Q319Q421Q122Q223Q324Q426Q126Q2 Net change in holders (bars) Total funds holding (line)

What happened after each past buying rush 6 times in its history

Quarter of the rush How unusual then Price, next 3 months Price, next 6 months
2026Q1 Top 5% — —
2025Q3 Top 20% — —
2025Q2 Top 20% — —
2024Q1 Top 20% — —
2018Q1 Top 10% — —
2017Q1 Top 10% — —

These are the raw price moves, not how much it beat the market by. Compare them against the market over the same months — in a strong bull market almost everything is up.

Show all the numbers (large funds, value held, options…) ▾
Of them, large funds
100
Change in large funds
+18
Total value they hold
$794M
Funds buying for the first time
49
Funds that sold out entirely
49
Price change that quarter
—
Funds holding puts (bearish)
3
Funds holding calls (bullish)
5

These are for people who want to dig. Skip them if they do not mean anything to you — the three numbers above are enough.

8,697 institutions have filed for this quarter. 13F permits late filing and a small number arrive in the weeks after the deadline, so the holder counts and changes below may tick up.

Fundamentals

PE (TTM)
—
EPS (TTM)
$-0.61
EPS YoY
-208.9%
Revenue (TTM)
$0.0B
Revenue YoY
-87.0%
Net margin
-435.2%
ROE
-26.4%
Debt ratio
20.8%
FCF (TTM)
-$82M
Dividend (TTM)
No dividend
Quarterly Revenue & EPS
2021-09-30: EPS -0.35 2021-12-31: EPS -0.90 2022-03-31: EPS -0.49 2022-06-30: EPS -0.45 2022-09-30: EPS -0.44 2022-12-31: EPS -0.13 2023-03-31: EPS -0.05 2023-06-30: EPS -0.02 2023-09-30: EPS 0.04 2023-12-31: EPS 0.02 2024-03-31: EPS 0.17 2024-06-30: EPS -0.08 2024-09-30: EPS 0.07 2024-12-31: EPS 0.22 2025-03-31: EPS 0.27 2025-06-30: EPS 0.00 2025-09-30: EPS -0.09 2025-12-31: EPS -0.33 2026-03-31: EPS -0.10 2026-06-30: EPS -0.09 0M 25M 51M $M -0.99 -0.35 0.30 2016201720182019202020212022202320242025202606/26 Revenue EPS

Quarterly figures, revenue up to 10 years back; EPS split-adjusted, early quarters hidden when not calibrable

Quarterly free cash flow
-51M61M173M 20162017201820192020202120222023202420252026
Latest quarter $-26M (2026-03-31)

FCF = operating cash flow − capex, computed from SEC XBRL; banks/insurers have no standard cash-flow structure and are hidden

As of 2026-06-30 · SEC filings (XBRL)

Email me the next update

2026 Q3 holdings are due 2026-11-16. We will email you when the refreshed lists are live.